产品
编 号：F107302
分子式：C12H17NO5
分子量：255.27
分子式：C12H17NO5
分子量：255.27
产品类型
规格
价格
是否有货
500mg
询价
询价
1g
询价
询价
结构图
CAS No: 127464-43-1
产品详情
生物活性：
Emoxypine succinate is an antioxidant. Emoxypine succinate can be used for the research of post-traumatic.
体内研究：
Emoxypine succinate (i.p.; 40 mg/kg; 1 time per day, 14 days) decreases the production of reactive oxygen species, mitochondrial transmembrane potential percentage of leukocyte and the percentage of FITC Annexin V- positive cells of leukocyte suspension.Animal Model:Rats
Dosage:40 mg/kg
Administration:Intraperitoneal, 1 time per day, 14 days
Result:Significantly increased the percentage of Annexin V-positive cells, reduced the apoptotic percentage of white blood cells and decreased the production of reactive oxygen species by leukocytes.
体外研究：
Emoxypine succinate shows reactive oxygen species overproduction and disruption of the mitochondrial inner membrane due to the decreasing of transmembrane potential.
Emoxypine succinate is an antioxidant. Emoxypine succinate can be used for the research of post-traumatic.
体内研究：
Emoxypine succinate (i.p.; 40 mg/kg; 1 time per day, 14 days) decreases the production of reactive oxygen species, mitochondrial transmembrane potential percentage of leukocyte and the percentage of FITC Annexin V- positive cells of leukocyte suspension.Animal Model:Rats
Dosage:40 mg/kg
Administration:Intraperitoneal, 1 time per day, 14 days
Result:Significantly increased the percentage of Annexin V-positive cells, reduced the apoptotic percentage of white blood cells and decreased the production of reactive oxygen species by leukocytes.
体外研究：
Emoxypine succinate shows reactive oxygen species overproduction and disruption of the mitochondrial inner membrane due to the decreasing of transmembrane potential.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备